Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Other (2016 - 2025)
Historic Receivables - Other for Viridian Therapeutics, Inc.\DE (VRDN) over the last 8 years, with Q3 2025 value amounting to $70.0 million.
- Viridian Therapeutics, Inc.\DE's Receivables - Other rose 49990000.0% to $70.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.0 million, marking a year-over-year increase of 49990000.0%. This contributed to the annual value of $102000.0 for FY2023, which is 0.0% changed from last year.
- According to the latest figures from Q3 2025, Viridian Therapeutics, Inc.\DE's Receivables - Other is $70.0 million, which was up 49990000.0% from $14000.0 recorded in Q3 2024.
- Viridian Therapeutics, Inc.\DE's Receivables - Other's 5-year high stood at $70.0 million during Q3 2025, with a 5-year trough of $14000.0 in Q3 2024.
- For the 5-year period, Viridian Therapeutics, Inc.\DE's Receivables - Other averaged around $5.6 million, with its median value being $128000.0 (2023).
- As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Receivables - Other tumbled by 8627.45% in 2024, and later skyrocketed by 49990000.0% in 2025.
- Viridian Therapeutics, Inc.\DE's Receivables - Other (Quarter) stood at $451000.0 in 2021, then plummeted by 77.38% to $102000.0 in 2022, then changed by 0.0% to $102000.0 in 2023, then plummeted by 86.27% to $14000.0 in 2024, then soared by 499900.0% to $70.0 million in 2025.
- Its last three reported values are $70.0 million in Q3 2025, $14000.0 for Q3 2024, and $102000.0 during Q1 2024.